ImmunoVec Launches from Stealth with up to $40.7 Million ARPA-H EMBODY Award to Advance In Vivo Cell Engineering Platform for Autoimmune Diseases
Novel platform uses DNA-loaded polymeric nanoparticles to precisely reprogram cells in patients, offering potential to reset the immune system and transform treatment for life-threatening autoimmune diseases ImmunoVec will conduct the multi-year award in collaboration with…